Skip to main content
Premium Trial:

Request an Annual Quote

Myriad Enlists Iceland Genomics to Help Hunt for Oncogenes

NEW YORK, June 20 - Myriad Genomics has tapped Iceland Genomics to help it hunt for cancer-causing genes, IGC said today.


Under the deal, IGC will use Myriad's batch of genetic markers together with its own sample-collection tools to identify the genes. In exchange, Myriad will award the Reykjavik-based company research and milestone payments as well as royalties on any products that might be developed.


Click here for more information.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.